Transcript Pigmenty - Univerzita Karlova v Praze

Dementia
Def.
decrease of individual
intelectual abilities under the
formerly reached niveau
Dementia
Clinical features
Disturbances of
memory
(mnestic)
 cognitive functions (gnostic)
 adaptative behaviour (practice)

Dementia
Beginning
mostly inapparent
Course
reversible
stationary
progredient
Dementia 




causes (1)
 MALNUTRITION
THERAPY
INTOXICATION  VASCULAR
INFECTION

EXPANSION
METABOLIC  AFFECTIVE
DISORDERS
DISORDERS
PROGRESSIVE DEGENERATIVE
DISEASES
Dementia 

causes (2)
THERAPY
polypragmasia
INTOXICATION
Mn, Cu, Pb,
CO, CS2, Hg, etanol…..

INFECTION
viral, bacterial
protozoan, mycotic
(HIV, PME, Whipple disease, Lues,
toxoplasmosis, cryptococcosis, prion dis.)
Prionoses
- morphology

neuronal loss

spongiosis

gliosis
ATROPHY
Dementia -
causes (3)
METABOLIC DISORDERS

chron. liver or kidney failure,
thesaurismoses
hepatolenticular degeneration
MALNUTRITION



avitaminosis B1
Wernicke-Korsakoff encephalopathy
with dementia
Storage Diseases
Def.:
inborn errors of metabolism (mostly
single gene abnormality) leading to an
 enzyme defect with subsequent
 accumulation of the substrate (&
 lack of the product) in tissues or
organs
Lipid Storage Diseases -1.
Disease
E- def
Accum.
Lipid
Tay-Sachs Hexos
GM2
aminidase A ganglioside
Gaucher
Gluco
Glucosidase cerebrosid
Tissues
Involved
Brain,
retina
Liver, spleen,
bone marrow,
brain
NiemannPick
Sphingo
myelinase
Sphingo
myelin
Brain, liver
spleen
Lipid Storage Diseases – 2.
Disease
E- def
Metachro
matic
Leuco
dystrophy
Fabry´s
Arylsulfat
ase A
Krabbe´s
-galactosid
ase
Galactosyl
ceramidase
Accum.
Lipid
Sulfatid
Tissues
Involved
Brain, kidney,
liver, peripheral
nerves
Ceramid
trihexosid
Skin, kidney
Galactol
Brain
cerebroside
Mucopolysaccharidoses
Disease,
E- def
inheritance
course
Hurler
-liduronidase
AR, severe
Hunter
X, rec.
moderate
Sanfilippo
liduronosulf
ate
sulfatase
Many types
Accum.
Mucopoly
saccharide
Heparan
sulfate,
dermatan
sulfate
Heparan
sulfate,
dermatan
sulfate
Heparan
sulfate
Tissues
Involved
Skin, cornea,
bone heart,
Brain, liver
spleen
Skin, bone,
heart, ear,
retina
Brain, skin
Dementia

– causes (4)
VASCULAR
hypertensive encephalopathy,
MID

EXPANSION
subdural hematoma, hygroma,
neoplasia, hydrocephalus

AFFECTIVE DISORDERS
depression
Dementia -
causes (5)
PROGRESSIVE DEGENERATIVE
DISEASES
 dementia – the only one symptome:
m. Alzheimer, m. Pick

dementia – combined with neurology
symptomes:
m. Parkinson, m. Huntington, ALS, PP
M. Alzheimeri - incidence
 65 yrs
 80 yrs
5%
population
20%
M. Alzheimeri
Extracellular
 -amyloid
plaques
 dystrophic dendrites
 axons
 activated microglia
 reactive astrocytes
diffuse plaques - A42
mature plaques - A42
and
A40
M. Alzheimeri
Intracellular
 neurofibrillary
deposits
hyperphosphorylated
proteins (pair helical
filaments)
glycosaminoglycans
admixture (heparin)
M. Alzheimeri- genetic factors
Chromo
-some
Gene defekt
Age
of onset
A phenotype
50s
Production of total A 42
peptides
60and
older
Density of Aplaques
and vascular deposits
21
 APP mutations
19
apo E4
polymorphism
14
presenilin 1
mutations
40s and
50s
Production of A 42
peptides
1
presenilin 2
mutations
50s
Production of A 42
peptides
M. Alzheimeri - diagnosis
age matched
neuritic plaques
quantity
Khachaturyan, Mirra et al.
Dementia -
causes (5)
PROGRESSIVE DEGENERATIVE
DISEASES
 dementia – the only one symptome:
m. Alzheimer, m. Pick

dementia – combined with neurology
symptomes:
m. Parkinson, m. Huntington, ALS, PP
Dementia -
causes (5)
PROGRESSIVE DEGENERATIVE
DISEASES
 dementia – the only one symptome:
m. Alzheimer, m. Pick

dementia – combined with neurology
symptomes:
m. Parkinson, m. Huntington, ALS, PP
Paralysis agitans
– m. Parkinsoni (1817)
Clinical features
 Start 40–60 years
 Early stage
 dysesthesias
 discrete

tremor
hypertonia–hypokinesis syndrome
tremor
rigidity
loss of automatic movements
prognosis: quoad vitam good,
quoad sanationem  (L-DOPA, transpl., nicotine)




Paralysis agitans
– m. Parkinsoni (1817)
Morphology

macroscopy
depigmentation of
substantia nigra mesencephali

microscopy
Lewy bodies ,
loss of pigmented neurons
Chorea chronica
progressiva Huntington

Autosomally dominant (!)
4th chromosome

Manifestation 25 – 45 years
(juvenile form prior to 20 years of age)

Duration 15 years
Chorea chronica
progressiva Huntington
Clinical features



contravolitional uncontrolled
dance–like motions
schizophrenic and depressive
personality features
death from intercurrent infection
Chorea chronica
progressiva Huntington
Morphology

macroscopy striatum atrophy
(ncl. caudatus + putamen)

microscopy loss of small GABA
neurons (norm. 80% of
population)
Sclerosis cerebrospinalis
multiplex disseminata MS
Def.
chronic autoimmune
disease with myelin breakdown
Sclerosis cerebrospinalis
multiplex disseminata MS
Clinical features
Disorders of



Course


sight
sensation
motorics
cont. progressive
saw-like
Sclerosis cerebrospinalis
multiplex disseminata MS
Morphological features
– myelinic plaques
acute
 chronic

Sclerosis cerebrospinalis
multiplex disseminata MS
Pathogenesis
 genetic predisposition
 viruses
MS – viral influence (morbilli,
herpes,…)
Pathogenesis
 interaction macroorganism x virus
limited production of Ig (only 10-20%
produced viruses are virulent)

virus mutation & immunosuppression
(age, pregnancy, stress, other disease)
MS – viral influence
(2)
Pathogenesis
 infection of endothelia – microangiitis
 hematoencephalic barier disorder
 serum and CSF
CD4,
CD8
(mirror image to AIDS)